Physicochemical Analysis Dr. Hanna Hartmann Head of Biomedicine & Material Sciences Group Leader Regenerative Biomaterials +49 7121 51530-872 E-Mail anzeigen Dr. Xin Xiong Group Leader Biofunctionaliz

Preclinical Stem Cell Models (CNS) Dr. Udo Kraushaar Group Leader Electrophysiology +49 7121 51530-851 E-Mail anzeigen Human stem cells for drug development Stem cell technologies such as induced plur

Neuronal plasticity within the basolateral amygdala (BLA) is fundamental for fear learning. Metaplasticity, the regulation of plasticity states, has emerged as a key mechanism mediating the subsequent

Young researchers in Reutlingen: A group of students from Albstadt-Sigmaringen University spent the last three days at the NMI and gained an insight into the work of the researchers. Young researchers

Data privacy Data protection We are pleased about your visit to our website. In the following, we will inform you about which personal data we collect and what happens to this data when you visit our

History Foundation and development of the NMI The state needs more application orientation The impetus for founding the NMI came in 1983 from Dr. Günter Hoff, head of research in the "New Technologies

The collaborative project FoBioGel aims at the development of photo-structurable, biochemically functionalizable hydrogels in the sense of a technology platform. These hydrogels are to be used as a bi

The aim of the project is to identify early biological indicators to predict the effects of non-genotoxic carcinogens

Non-invasive diagnostic approach to determine patient risk from tumor metastasis based on circulating tumor cells. Individual therapy success and survival rate of tumor patients depend to a large exte

Early detection of negative effects of immunotherapeutic drug substances using innovative, highly complex, human organotypical co-culture systems combined with systems biology-based signaling pathway